Furthermore, silencing of HDAC2 can also increase the sensitivity of GBM cells to temozolomide (TMZ), which might be due to the significant down-regulation of the multidrug resistance-associated protein 1 (MRP1) [190]. This evidence concerns the gene ABCC1 and glioblastoma.